| Sun Pharma Advanced Research Company Ltd | Industry : (Pharmaceuticals) | |
|---|---|---|
|
BSE Code : 532872 |
NSE Symbol : SPARC |
P/E(TTM) : - |
|
ISIN Demat : INE232I01014 |
Div & Yield% : - |
EPS(TTM) : - |
|
Book Value(₹) : 3.85 |
Market Cap(₹Cr) : 7,092.42 |
Face Value(₹) : 1.00 |
| Particulars | Mar '24 | Mar '23 | Mar '22 | Mar '21 | Mar '20 |
|---|---|---|---|---|---|
| INCOME : | |||||
| Sales Turnover | 75.55 | 238.78 | 137.25 | 252.96 | 76.81 |
| Excise Duty | - | - | - | - | - |
| Net Sales | 75.55 | 238.78 | 137.25 | 252.96 | 76.81 |
| Other Income | 29.47 | 10.88 | 6.84 | 5.41 | 9.76 |
| Stock Adjustments | - | - | - | - | - |
| Total Income | 105.02 | 249.66 | 144.09 | 258.37 | 86.57 |
| EXPENDITURE : | |||||
| Raw Materials | - | - | 18.27 | 18.18 | 23.93 |
| Power and Fuel Cost | 6.14 | 5.75 | 4.62 | 4.60 | 5.14 |
| Other Manufacturing Expenses | 55.37 | 45.51 | 17.06 | 17.93 | 10.59 |
| Selling and Administration Expenses | 292.27 | 289.71 | 183.33 | 252.17 | 247.28 |
| Miscellaneous Expenses | 7.03 | 4.87 | 2.41 | 3.48 | 6.81 |
| Employee Benefit Expenses | 118.53 | 107.00 | 98.31 | 91.59 | 93.09 |
| Less: Preoperative Expenditure | - | - | - | - | - |
| Total Expenses | - | - | - | - | - |
| Operating Profit | -374.32 | -203.18 | -179.90 | -129.57 | -300.25 |
| Interest | 1.66 | 7.63 | 13.33 | 10.65 | 2.67 |
| Gross Profit | -375.98 | -210.81 | -193.23 | -140.22 | -302.92 |
| Depreciation | 12.13 | 11.77 | 10.16 | 10.92 | 9.48 |
| Profit Before Tax | -388.11 | -222.58 | -203.39 | -151.14 | -312.40 |
| Current Tax | - | - | - | - | - |
| Fringe Benefit tax | - | - | - | - | - |
| Deferred Tax | - | - | - | - | - |
| Reported Net Profit | -388.11 | -222.58 | -203.40 | -151.14 | -312.40 |
| Extraordinary Items | 0.58 | -0.11 | 4.89 | 0.26 | 6.27 |
| Adjusted Net Profit | -388.69 | -222.47 | -208.29 | -151.40 | -318.67 |
| Adjustment below Net Profit | 0.19 | 1.35 | 1.70 | 1.53 | -2.47 |
| Profit/Loss Balance carried down | -1,591.81 | -1,370.58 | -1,168.88 | -1,019.27 | -704.40 |
| Statutory Appropriations | - | - | - | - | - |
| Appropriations | - | - | - | - | - |
| P & L Balance carried down | -1,979.73 | -1,591.81 | -1,370.58 | -1,168.88 | -1,019.27 |
| Dividend | - | - | - | - | - |
| Preference Dividend | - | - | - | - | - |
| Equity Dividend (%) | - | - | - | - | - |
| Dividend Per Share(Rs) | - | - | - | - | - |
| Earnings Per Share-Unit Curr | -11.96 | -6.86 | -7.48 | -5.77 | -11.92 |
| Earnings Per Share(Adj)-Unit Curr | -11.96 | -6.86 | -7.48 | -5.77 | -11.92 |
| Book Value | 3.85 | 15.80 | -7.47 | -6.42 | -0.71 |
| Book Value(Adj)-Unit Curr | 3.85 | 15.80 | -7.47 | -6.42 | -0.71 |